Kelly Goonan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kelly Goonan has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
David C Goff
2 shared publications- Alain Gerald Bertoni
Wake Forest University School of Medicine, Winston-Salem, NC, USA
1 shared publication - Angela M. Pikus
Atrium Health's Carolinas Medical Center Department of Emergency Medicine Charlotte North Carolina
1 shared publication - Anthony J. Weekes
Department of Emergency Medicine, Atrium Health’s Carolinas Medical Center, Charlotte, USA
1 shared publication Ariana Trautmann
Department of Emergency Medicine Atrium Health’s Carolinas Medical Center Charlotte North Carolina USA
1 shared publicationBruce P. Levy
Division of Informatics, Geisinger Health, Danville, Pennsylvania, United States
1 shared publication
Latest Publications
- Open Access
- 22 March 2024
- Published by Wiley in Critical Care Research and Practice
- Vol. 2024, 1-17
Comparison of Treatment Approaches and Subsequent Outcomes within a Pulmonary Embolism Response Team Registry
Objectives. To characterize the association between pulmonary embolism (PE) severity and bleeding risk with treatment approaches, outcomes, and complications. Methods. Secondary analysis of an 11-hospital registry of adult ED patients treated by a PE response team (August 2016November 2022). Predictors were PE severity and bleeding risk. The primary outcome was treatment approach: anticoagulation monotherapy vs. advanced intervention (categorized as immediate or delayed based on whether the intervention was received within 12hours of PE diagnosis or not). Secondary outcomes were death, clinical deterioration, and major bleeding. Results. Of the 1832 patients, 139 (7.6), 977 (53.3), and 9 (0.5) were classified as high-risk, intermediate-high, intermediate-low, and low-risk severity, respectively. There were 94 deaths (5.1) and 218 patients (11.9) had one or more clinical deterioration events. Advanced interventions were administered to 86 (61.9), 195 (27.6), and 109 (11.2) patients with high-risk, intermediate-high, and intermediate-low severity, respectively.Major bleeding occurred in 61/1440 (4.2) on ACm versus 169/392 (7.6) with advanced interventions (p Conclusions. Advanced intervention use was associated with high-acuity patients experiencing death, clinical deterioration, and major bleeding with a trend towards less bleeding with catheter-directed interventions versus systemic thrombolysis.
- 22 March 2024
- Published by Wiley in Critical Care Research and Practice
- Vol. 2024, 1-17
Open AccessComparison of Treatment Approaches and Subsequent Outcomes within a Pulmonary Embolism Response Team Registry
Objectives. To characterize the association between pulmonary embolism (PE) severity and bleeding risk with treatment approaches, outcomes, and complications. Methods. Secondary analysis of an 11-hospital registry of adult ED patients treated by a PE response team (August 2016November 2022). Predictors were PE severity and bleeding risk. The primary outcome was treatment approach: anticoagulation monotherapy vs. advanced intervention (categorized as immediate or delayed based on whether the intervention was received within 12hours of PE diagnosis or not). Secondary outcomes were death, clinical deterioration, and major bleeding. Results. Of the 1832 patients, 139 (7.6), 977 (53.3), and 9 (0.5) were classified as high-risk, intermediate-high, intermediate-low, and low-risk severity, respectively. There were 94 deaths (5.1) and 218 patients (11.9) had one or more clinical deterioration events. Advanced interventions were administered to 86 (61.9), 195 (27.6), and 109 (11.2) patients with high-risk, intermediate-high, and intermediate-low severity, respectively.Major bleeding occurred in 61/1440 (4.2) on ACm versus 169/392 (7.6) with advanced interventions (p Conclusions. Advanced intervention use was associated with high-acuity patients experiencing death, clinical deterioration, and major bleeding with a trend towards less bleeding with catheter-directed interventions versus systemic thrombolysis.
- Open Access
- 1 January 2020
- Published by Georg Thieme Verlag KG in ACI Open
- Vol. 04 (01) , e22-e29
KOI Pond: The “Elevator Pitch” that Adapts to Describe the Breadth and Variety of Clinical Informatics Practice
Background The practice of clinical informatics (CI) is diverse and frequently tailored to individual skills and interests or to organizational/departmental needs. Prior studies have sought to define core content areas, educational milestones, and practice patterns within the clinical informatics subspecialty (CIS). Unfortunately, no single tool or framework currently exists that can succinctly define an informatician's role regardless of setting. The diversity of informatics practice makes it difficult to have one “pitch” that describes all possible domains, tasks, knowledge, and skills available to an informatician. Objective Using qualitative data from multiple informaticians, provide a succinct framework to describe and compartmentalize the various functions an informatician can contribute to the healthcare field. Methods We created an iterative focus group of five CIS fellows enrolled in different fellowship programs nationwide, one CIS program director, and an MD-PhD candidate in biomedical informatics. After much discussion, iteration, and consideration of career options within a young and burgeoning subspecialty, a dual-axis model was created that describes CIS practice in terms of settings (internal, external, and policy) and focus areas (knowledge, operations, and innovation). Results and Conclusion By combining both axes into a single “KOI pond” and then prioritizing sections by interest/resource investment, we are able to generate a unique snapshot for each informatician. These snapshots can be used (1) by informaticians to characterize their own practice succinctly as a pitch, (2) by CIS fellows who are considering career options, and (3) by those unfamiliar with CIS who want to learn more.
- 1 January 2020
- Published by Georg Thieme Verlag KG in ACI Open
- Vol. 04 (01) , e22-e29
Open AccessKOI Pond: The “Elevator Pitch” that Adapts to Describe the Breadth and Variety of Clinical Informatics Practice
Background The practice of clinical informatics (CI) is diverse and frequently tailored to individual skills and interests or to organizational/departmental needs. Prior studies have sought to define core content areas, educational milestones, and practice patterns within the clinical informatics subspecialty (CIS). Unfortunately, no single tool or framework currently exists that can succinctly define an informatician's role regardless of setting. The diversity of informatics practice makes it difficult to have one “pitch” that describes all possible domains, tasks, knowledge, and skills available to an informatician. Objective Using qualitative data from multiple informaticians, provide a succinct framework to describe and compartmentalize the various functions an informatician can contribute to the healthcare field. Methods We created an iterative focus group of five CIS fellows enrolled in different fellowship programs nationwide, one CIS program director, and an MD-PhD candidate in biomedical informatics. After much discussion, iteration, and consideration of career options within a young and burgeoning subspecialty, a dual-axis model was created that describes CIS practice in terms of settings (internal, external, and policy) and focus areas (knowledge, operations, and innovation). Results and Conclusion By combining both axes into a single “KOI pond” and then prioritizing sections by interest/resource investment, we are able to generate a unique snapshot for each informatician. These snapshots can be used (1) by informaticians to characterize their own practice succinctly as a pitch, (2) by CIS fellows who are considering career options, and (3) by those unfamiliar with CIS who want to learn more.
- 1 March 2005
- Vol. 97 (3) , 317-23
Racial and ethnic disparities in cardiac catheterization for acute myocardial infarction in the United States, 1995--2001.
To examine recent trends in racial and ethnic disparities in cardiac catheterization for acute myocardial infarction (AMI) to determine whether disparities documented from the 1980s through mid-1990s persist, and evaluate whether patient and hospital characteristics are associated with any observed disparities Cross-sectional analyses of 585,710 white, 51,369 black and 31,923 Hispanic discharges from hospitals in the Nationwide Inpatient Sample (which includes data on all discharges from 951 representative hospitals in 23 states) that had performed cardiac catheterization from 1995--2001 with a primary diagnosis of AMI. Adjusted procedure rates and prevalence ratios (PR) were computed to compare catheterization rates by race and ethnicity. Catheterization rates were higher for whites than blacks for all years examined; rates among Hispanics increased during this period and approached the rate among whites. After adjustment for age, demographics, comorbidity, year and hospital characteristics, rates (per 100 discharges) were 58.4 for whites, 50.1 for blacks (PR 0.87; 95% CI 0.84-0.91) and 55.2 for Hispanics (PR 0.95; 95% CI 0.90-0.99). These nationwide data suggest blacks remain less likely than whites and Hispanics to undergo catheterization during a hospitalization for AMI. Whether this disparity stems from patient or provider factors remains to be determined.
- 1 March 2005
- Vol. 97 (3) , 317-23
Racial and ethnic disparities in cardiac catheterization for acute myocardial infarction in the United States, 1995--2001.
To examine recent trends in racial and ethnic disparities in cardiac catheterization for acute myocardial infarction (AMI) to determine whether disparities documented from the 1980s through mid-1990s persist, and evaluate whether patient and hospital characteristics are associated with any observed disparities Cross-sectional analyses of 585,710 white, 51,369 black and 31,923 Hispanic discharges from hospitals in the Nationwide Inpatient Sample (which includes data on all discharges from 951 representative hospitals in 23 states) that had performed cardiac catheterization from 1995--2001 with a primary diagnosis of AMI. Adjusted procedure rates and prevalence ratios (PR) were computed to compare catheterization rates by race and ethnicity. Catheterization rates were higher for whites than blacks for all years examined; rates among Hispanics increased during this period and approached the rate among whites. After adjustment for age, demographics, comorbidity, year and hospital characteristics, rates (per 100 discharges) were 58.4 for whites, 50.1 for blacks (PR 0.87; 95% CI 0.84-0.91) and 55.2 for Hispanics (PR 0.95; 95% CI 0.90-0.99). These nationwide data suggest blacks remain less likely than whites and Hispanics to undergo catheterization during a hospitalization for AMI. Whether this disparity stems from patient or provider factors remains to be determined.
- 31 May 2003
- Vol. 64 (1) , 4-10
Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
Effective therapy for chronic heart failure (CHF) is underutilized despite a broad consensus regarding treatment recommendations. As a quality improvement project designed to reduce preventable hospitalizations associated with CHF, we examined use of angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and beta-adrenergic receptor blockers (BB) in a population of patients enrolled in a managed care plan. Medicare and commercial enrollees were included. Patients with CHF were identified using claims data (International Classification of Disease 9th Clinical Modification code 428) covering January 1, 1998 through December 31, 1998. Drug utilization data were obtained from the plan's pharmacy benefits database. Data were available for 1220 patients. The mean age (+/- SD) was 71 +/- 12 years, 53% were female, and 84% were Medicare enrollees. Prescriptions for ACEI, ARB and BB were filled by 52%, 9% and 25% of patients, respectively. Prescriptions for diuretics, digitalis preparations, and calcium channel blockers (CCB) were filled by 69%, 34%, and 32%, respectively. Therefore, almost half of patients with CHF were not receiving ACEI therapy, even though it had been proven to reduce morbidity and mortality related to CHF. Furthermore, three-quarters of patients were not receiving BB therapy, a similarly effective therapy. In contrast, CCB and digitalis have not been convincingly shown to reduce mortality in patients with CHF broadly defined. Utilization of CCB and digitalis exceeded that of BB. Managed care organizations should develop, test, and implement network-level strategies designed to optimize the appropriate utilization of effective drug therapies for patients with CHF.
- 31 May 2003
- Vol. 64 (1) , 4-10
Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
Effective therapy for chronic heart failure (CHF) is underutilized despite a broad consensus regarding treatment recommendations. As a quality improvement project designed to reduce preventable hospitalizations associated with CHF, we examined use of angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and beta-adrenergic receptor blockers (BB) in a population of patients enrolled in a managed care plan. Medicare and commercial enrollees were included. Patients with CHF were identified using claims data (International Classification of Disease 9th Clinical Modification code 428) covering January 1, 1998 through December 31, 1998. Drug utilization data were obtained from the plan's pharmacy benefits database. Data were available for 1220 patients. The mean age (+/- SD) was 71 +/- 12 years, 53% were female, and 84% were Medicare enrollees. Prescriptions for ACEI, ARB and BB were filled by 52%, 9% and 25% of patients, respectively. Prescriptions for diuretics, digitalis preparations, and calcium channel blockers (CCB) were filled by 69%, 34%, and 32%, respectively. Therefore, almost half of patients with CHF were not receiving ACEI therapy, even though it had been proven to reduce morbidity and mortality related to CHF. Furthermore, three-quarters of patients were not receiving BB therapy, a similarly effective therapy. In contrast, CCB and digitalis have not been convincingly shown to reduce mortality in patients with CHF broadly defined. Utilization of CCB and digitalis exceeded that of BB. Managed care organizations should develop, test, and implement network-level strategies designed to optimize the appropriate utilization of effective drug therapies for patients with CHF.
- 1 August 2001
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 21 (2) , 124-131
Quality of diabetes care among low-income patients in North Carolina
- 1 August 2001
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 21 (2) , 124-131
Quality of diabetes care among low-income patients in North Carolina
- 3 December 1999
- Vol. 60 (6) , 346-50
Diabetes-related leg amputations in elderly North Carolinians. A status report and a challenge.
- 3 December 1999
- Vol. 60 (6) , 346-50
Diabetes-related leg amputations in elderly North Carolinians. A status report and a challenge.